Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
STA Pharmaceutical
STA Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Manufacturing Chemist Live: Day One Review
The first day of MC Live has now concluded, with attendees enjoying presentations from STA Pharmaceuticals, NSF International and Lonza, among others
Manufacturing
Process optimisation with biocatalysis
From route scouting, screening and scale-up to commercial production, Dr Jingyang Zhu, VP Process Chemistry Enabling Technologies at WuXi, discusses the services and capabilities of a modern CDMO
Manufacturing
Process optimisation with flow chemistry
WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more cost-effective technologies and expedite their time to market
Drug Delivery
BioLingus partnership boosts WuXi STA’s solid dose potential
The collaboration will use BioLingus' technology to focus on sublingual and buccal drug delivery
Subscribe now